Literature DB >> 21874156

Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro Study.

Majed A Refaai1, Kelly F Henrichs, Sherry L Spinelli, Richard P Phipps, Edward Masel, Brian H Smith, Charles W Francis, Neil Blumberg.   

Abstract

Since platelets possess A and B antigen, mismatched ABO platelets could, theoretically, become activated or hypofunctional by exposure to anti-A or anti-B antibodies found in transfused or recipient plasma. Following normal baseline platelet aggregation to adenosine diphosphate (ADP), platelets from normal donors of different blood types were incubated at 37°C for 10 minutes with 50μl of normal saline (NS), O plasma, or AB plasma. Aggregation was then induced with ADP. No significant changes from baseline were seen in platelet aggregation studies following incubation with NS. However, platelet aggregations of type A and type B platelets were significantly inhibited when incubated with O plasma (mean of 41 and 22%, respectively). Our findings indicate that mediators in group O plasma, very likely anti-A and anti-B antibodies, cause impaired platelet aggregation of ABO non-identical platelets.

Entities:  

Year:  2011        PMID: 21874156      PMCID: PMC3162317          DOI: 10.17925/ohr.2011.07.1.72

Source DB:  PubMed          Journal:  US Oncol Hematol        ISSN: 2045-6344


  16 in total

1.  Blood group A and B antigens are strongly expressed on platelets of some individuals.

Authors:  B R Curtis; J T Edwards; M J Hessner; J P Klein; R H Aster
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

Review 2.  Platelets in inflammation and thrombosis.

Authors:  Denisa D Wagner; Peter C Burger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-18       Impact factor: 8.311

3.  Blood collection and transfusion in the United States in 1999.

Authors:  Marian T Sullivan; Edward L Wallace
Journal:  Transfusion       Date:  2005-02       Impact factor: 3.157

4.  Platelet transfusion and survival in adults with acute leukemia.

Authors:  N Blumberg; J M Heal; J L Liesveld; G L Phillips; J M Rowe
Journal:  Leukemia       Date:  2007-09-06       Impact factor: 11.528

5.  Study on the expression of ABH antigens on platelets.

Authors:  K Ogasawara; J Ueki; M Takenaka; K Furihata
Journal:  Blood       Date:  1993-08-01       Impact factor: 22.113

6.  Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery.

Authors:  N Blumberg; J M Heal; G L Hicks; W H Risher
Journal:  Transfusion       Date:  2001-06       Impact factor: 3.157

Review 7.  Clinical and laboratory factors underlying refractoriness to platelet transfusions.

Authors:  R C Friedberg
Journal:  J Clin Apher       Date:  1996       Impact factor: 2.821

8.  Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.

Authors:  Alok A Khorana; Charles W Francis; Neil Blumberg; Eva Culakova; Majed A Refaai; Gary H Lyman
Journal:  Arch Intern Med       Date:  2008-11-24

9.  Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma.

Authors:  A Shanwell; T M-L Andersson; K Rostgaard; G Edgren; H Hjalgrim; R Norda; M Melbye; O Nyrén; M Reilly
Journal:  Vox Sang       Date:  2009-02-24       Impact factor: 2.144

10.  A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440].

Authors:  Neil Blumberg; Joanna M Heal; Jacob M Rowe
Journal:  BMC Blood Disord       Date:  2004-12-10
View more
  1 in total

1.  Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B.

Authors:  Majed A Refaai; Jessie Carter; Kelly F Henrichs; Donna C Davidson; Stephen J Pollock; Ann E Casey; Sherry L Spinelli; Richard P Phipps; Charles W Francis; Neil Blumberg
Journal:  Transfusion       Date:  2012-05-25       Impact factor: 3.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.